159 related articles for article (PubMed ID: 1325216)
1. Value of cytometric analysis for distinction of intraductal carcinoma of the breast.
Fisher ER; Siderits R
Breast Cancer Res Treat; 1992; 21(3):165-72. PubMed ID: 1325216
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
3. The histologic spectrum of apocrine breast proliferations: a comparative study of morphology and DNA content by image analysis.
Raju U; Zarbo RJ; Kubus J; Schultz DS
Hum Pathol; 1993 Feb; 24(2):173-81. PubMed ID: 8381766
[TBL] [Abstract][Full Text] [Related]
4. DNA analysis of ductal carcinoma in situ of the breast. A comparison with histologic features.
Killeen JL; Namiki H
Cancer; 1991 Dec; 68(12):2602-7. PubMed ID: 1657363
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric DNA analysis of breast cancers with predominance of carcinoma in situ: a comparison of the premalignant and malignant components.
Ottesen GL; Christensen IJ; Larsen JK; Hansen B; Andersen AJ
Clin Cancer Res; 1995 Aug; 1(8):881-8. PubMed ID: 9816058
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric DNA analysis of specimen mammography-guided fine-needle aspirates of ductal carcinoma in situ.
Stomper PC; DeBloom JR; Winston JS; Stewart CC
J Exp Clin Cancer Res; 2000 Sep; 19(3):309-15. PubMed ID: 11144524
[TBL] [Abstract][Full Text] [Related]
7. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
[TBL] [Abstract][Full Text] [Related]
8. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions.
Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT
J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376
[TBL] [Abstract][Full Text] [Related]
9. Importance of cellular DNA content in pre-malignant breast disease and pre-invasive carcinoma of the female breast.
Carpenter R; Gibbs N; Matthews J; Cooke T
Br J Surg; 1987 Oct; 74(10):905-6. PubMed ID: 2822199
[TBL] [Abstract][Full Text] [Related]
10. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.
Pinder SE; Ellis IO
Breast Cancer Res; 2003; 5(5):254-7. PubMed ID: 12927035
[TBL] [Abstract][Full Text] [Related]
11. Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast.
Crissman JD; Visscher DW; Kubus J
Arch Pathol Lab Med; 1990 Dec; 114(12):1249-53. PubMed ID: 2174672
[TBL] [Abstract][Full Text] [Related]
12. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
Tsang WY; Chan JK
Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
[TBL] [Abstract][Full Text] [Related]
13. Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma.
Moriya T; Silverberg SG
Cancer; 1994 Dec; 74(11):2972-8. PubMed ID: 7954261
[TBL] [Abstract][Full Text] [Related]
14. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
Piubello Q; Montemezzi S; D'Atri C
Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
[TBL] [Abstract][Full Text] [Related]
15. AgNOR analysis of atypical ductal hyperplasia and intraductal carcinoma of the breast.
Guski H; Hufnagl P; Kaufmann O; Krause M; Winzer KJ
Anal Quant Cytol Histol; 2000 Jun; 22(3):206-12. PubMed ID: 10872036
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric and histological analysis of ductal carcinoma in situ of the breast.
Locker AP; Horrocks C; Gilmour AS; Ellis IO; Dowle CS; Elston CW; Blamey RW
Br J Surg; 1990 May; 77(5):564-7. PubMed ID: 2162231
[TBL] [Abstract][Full Text] [Related]
17. Quantitative study of breast cancer progression: different pathways for various in situ cancers.
Mariuzzi L; Mombello A; Granchelli G; Rucco V; Tarocco E; Frank D; Davis J; Thompson D; Bartels H; Mariuzzi GM; Bartels PH
Mod Pathol; 2002 Jan; 15(1):18-25. PubMed ID: 11796837
[TBL] [Abstract][Full Text] [Related]
18. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma.
Goldstein NS; O'Malley BA
Am J Clin Pathol; 1997 May; 107(5):561-6. PubMed ID: 9128269
[TBL] [Abstract][Full Text] [Related]
19. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
Boecker W; Buerger H; Schmitz K; Ellis IA; van Diest PJ; Sinn HP; Geradts J; Diallo R; Poremba C; Herbst H
J Pathol; 2001 Nov; 195(4):415-21. PubMed ID: 11745672
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.
Poller DN; Snead DR; Roberts EC; Galea M; Bell JA; Gilmour A; Elston CW; Blamey RW; Ellis IO
Br J Cancer; 1993 Jul; 68(1):156-61. PubMed ID: 8100443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]